This report describes the elfects of two gram-negative bacterial endotoxin (lipopolysaccharide [LPS]) preparations on hamster pregnancy outcome variables. Single intravenous challenges with Escherichia coli and Porphyromonas gingivalis LPS on day 8 of pregnancy produced dose-dependent effects on fetal weight malformation and fetal resorption with E. coli LPS having potent embryolethal effects. Premating maternal exposure to P. gingivalis produced embryolethal effects similar to those of E. coli. These data suggest that maternal exposure to P. gingivalis LPS prior to and during pregnancy can induce deleterious effects on the developing fetus.
To date the effects of endotoxins of oral origin on the fetal-placental unit have not been examined. This is of potential significance since the molecular structure and biological activities of endotoxins isolated from oral organisms are different from those of enteric endotoxins. Experiments were conducted to compare the effects of enteric versus oral endotoxins on fetal development in the pregnant golden hamster model. In addition, studies were performed to characterize both the dose-response effects of lipopolysaccharide (LPS) on pregnant dams and the effects of immunization prior to LPS challenge on the pregnancy outcome.
Early experiments (1, 2, 5, 6) showed that enteric endotoxins are capable of inducing placental necrosis, spontaneous abortions, fetal organ damage, fetal death, and malformations in various animal species. Endotoxin was found to be embryolethal and to produce several malformations, spontaneous abortions, and low fetal weight. Administering Escherichia coli LPS as a single intravenous bolus on day 8 of gestation, Lanning (4) demonstrated a decrease in fetal weight and an increase in the percentage of malformed fetuses with increasing LPS concentrations.
It is our hypothesis that the burden of oral endotoxin which is associated with periodontal infection in humans may present a risk for abnormal pregnancy outcomes. Although there are considerable data indicating that systemic exposure to oral LPS occurs, especially in the presence of periodontal infection, the critical question remains as to whether oral endotoxins can elicit adverse pregnancy outcomes. In this report, we demonstrate that Porphyromonas gingivalis LPS can induce fetal growth retardation, fetal death, resorptions, and malformations and that the dose-response characteristics differ significantly from those of E. coli LPS. Furthermore, repeated immunization with P. gingivalis does not afford protection but, rather, appears to potentiate the abortifacient and embryotoxic effects of LPS challenge during pregnancy.
In these studies we have used P. gingivalis A7436, a clinical gingivalis LPS at various doses was administered at day 8 of pregnancy.
By comparing single doses of eitherE. coli or P. gingivalis LPS in the pregnant hamster, we have observed both qualitative and quantitative differences in pregnancy outcome responses. The effects of E. coli and P. gingivalis LPS on fetal weight are shown in Fig. 1 (Fig. 1A) at dosages of 0.03 and 0.3,ug of LPS per 100 gbw induced statistically significant increases in fetal weight (P < 0.01, nonpaired t test). However, as the LPS dosage increased there were statistically significant decreases in mean fetal weight with dosage of 10,ug/100 gbw, resulting in an 18.1% decrease (P < 0.01). The decrease in fetal weight in response to E. coli LPS occurred over a relatively narrow dose-response range, because as the LPS dose increases, the relative number of lethal fetal resorptions also increases (Fig. 2A) . The total number of implantation sites per female cannot change, since this event occurs prior to LPS challenge. Thus, as the E. coli LPS dose increases, the number and the size of the viable fetuses decrease. The effects of P.
gingivalis LPS on fetal weight are shown in Fig. 1B Fig. 2A) and the remaining viable fetuses are dramatically smaller (Fig. 1) . At 30 jig of E. coli LPS, there are no viable fetuses, as 100% of the implantation sites have resorbed. One-fourth of these animals also had signs of vaginal discharge. At doses of 100 ,ug, all of the animals showed vaginal discharge and 100% resorption upon sacrifice. In this dose range of 30 to 100 jig/100 gbw, piloerection and lethargy were observed as signs of fever and malaise; however, no effects were seen on maternal weight at any of the dosages tested. The maximum effect of P. gingivalis LPS on fetal mortality (Fig. 2B) all viable fetuses had visible skeletal malformations. Although not characterized systematically, malformations included neural crest defects and cleft palate and limb anomalies.
Although a single challenge with P. gingivalis LPS failed to demonstrate the same embryotoxicity as E. coli LPS, the effects of repeated treatment with either whole P. gingivalis or P. gingivalis LPS prior to mating on the pregnancy response elicited by a P. gingivalis LPS challenge during pregnancy are dramatic. Table 1 shows the effects of premating exposure with either P. gingivalis LPS or whole cells on pregnancy outcome. A single bolus of 1 ,ug of P. gingivalis LPS during pregnancy did not result in a significant effect on fetal weight as compared to controls. A single challenge of 3 ,ug of P. gingivalis LPS per 100 gbw during pregnancy resulted in a decrease in mean fetal weight from 1.55 g (control dams) to 1.4 ± 0.08 g. This is equivalent to a 9.7% reduction in weight. In contrast, animals that were primed with LPS before mating, and challenged with the same 3-,ug P. gingivalis LPS dose during pregnancy, had a more pronounced decrease in fetal weight (P = 0.02 This report demonstrates that the LPS from oral bacteria can cause adverse pregnancy outcomes. We have shown that increasing doses of LPS from both E. coli and P. gingivalis produce biphasic effects on fetal weight with significant decreases in fetal weight at higher doses. Single doses of E. coli LPS >10 ,ug/100 gbw were potent inducers of pathological mechanisms leading to fetal morbidity and mortality. The fact that single doses of P. gingivalis LPS failed to produce comparable responses appears to be a result of primary versus secondary challenge. Immunizing dams prior to mating with the P. gingivalis LPS increased the pathogenicity of the day 8 pregnancy challenge to levels comparable with those for E. coli. These findings pose new questions regarding the mechanisms of potential adverse effects of chronic oral infections with gram-negative organisms during pregnancy.
